GlassScriptPhysician profile
Cameron Blaine Carter
NPI 1447509443
$2,534.78
in general payments reported to CMS, 2019-2025
18 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,315 · 2024: $683 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,778 · Travel and Lodging: $460 · Education: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.60 |
| Travel and Lodging | $460.22 |
| Education | $296.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $460.22 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $336.77 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $299.99 | 2023 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $277.73 | 2023-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $217.20 | 2024-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $179.73 | 2023-2024 | Ilumya, Blu-U, Odomzo |
| Novartis Pharmaceuticals Corporation | $161.41 | 2023-2025 | |
| Ucb, INC. | $118.12 | 2023-2025 | Bimzelx, Cimzia |
| Amgen INC. | $113.01 | 2024-2025 | Otezla, Otezla |
| Leo Pharma INC. | $102.46 | 2024-2025 | Adbry, Anzupgo |
| Incyte Corporation | $77.92 | 2024-2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $67.34 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Dermavant Sciences, INC. | $34.36 | 2023-2024 | Vtama |
| Medline Industries LP | $19.93 | 2023 | |
| Convatec INC. | $19.73 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $17.72 | 2024 | Zoryve |
| Lnhc, INC | $16.07 | 2025 | Zelsuvmi |
| Pfizer INC. | $15.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.